United States · FDA National Drug Code directory
Varubi
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70720-101_5de36f8a-cbc2-4884-8fcf-e9302d41c2f8
- Product NDC
- 70720-101
- Form
- TABLET
- Composition / generic term
- rolapitant
- Labeler
- TerSera Therapeutics LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20151007
- Source listing expiry
- 20261231
Source-listed ingredients
- ROLAPITANT HYDROCHLORIDE — 90 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 2 TABLET in 1 BLISTER PACK (70720-101-02) · 70720-101-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →